Filing Details
- Accession Number:
- 0001571049-18-000334
- Form Type:
- 13D Filing
- Publication Date:
- 2018-06-07 17:03:37
- Filed By:
- William H.c. Chang & Diana Shon Chang Ttee Chang Family Trust U/a Dtd 10/23/2006
- Company:
- Semler Scientific Inc.
- Filing Date:
- 2018-06-07
- SEC Url:
- 13D Filing
Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.
| Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
|---|---|---|---|---|---|---|
| WILLIAM H.C. DIANA SHON CHANG TTEE CHANG FAMILY TRUST U A DTD | 0 | 1,400,419 | 0 | 1 | 1,400,419 | 23.5% |
| WILLIAM H.C. CHANG | 0 | 1,400,419 | 0 | 1 | 1,400,419 | 23.5% |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
(Amendment No. 6)
Under the Securities Exchange Act of 1934
SEMLER SCIENTIFIC, INC.
(Name of Issuer)
Common Stock, par value $0.001 per share
(Title of Class of Securities)
81684M 104
(CUSIP Number)
Yvan-Claude Pierre, Esq.
Marianne C. Sarrazin, Esq.
Cooley LLP
1114 Avenue of the Americas
New York, New York 10036-7798
Telephone: (212) 479-6000
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
April 20, 2018
(Date of Event Which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. ¨
| CUSIP No. 81684M 104 | Page 2 of 7 |
SCHEDULE 13D
| CUSIP No. 81684M 104 | |
| 1. | NAMES OF REPORTING PERSONS |
| WILLIAM H.C. & DIANA SHON CHANG TTEE CHANG FAMILY TRUST U/A/ DTD 10/23/2006 | |
| 2. | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP |
| (a) ¨ (b) ¨ | |
| 3. | SEC USE ONLY
|
| 4. | SOURCE OF FUNDS
PF |
| 5. | CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2 (e)
¨ |
| 6. | CITIZENSHIP OR PLACE OF ORGANIZATION
CALIFORNIA |
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 7. | SOLE VOTING POWER
0 shares |
| 8. | SHARED VOTING POWER
1,400,419 shares | |
| 9. | SOLE DISPOSITIVE POWER
0 shares | |
| 10. | SHARED DISPOSITIVE POWER
1,400,419 shares |
| 11. | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,400,419 shares |
| 12. | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
¨ |
| 13. | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
23.5%* |
| 14. | TYPE OF REPORTING PERSON*
OO |
* Based upon an aggregate of 5,954,689 shares of the Issuer’s (as defined below) common stock outstanding as of May 1, 2018 as reported in the Issuer’s Annual Report on Form 10-Q filed on May 3, 2018.
| CUSIP No. 81684M 104 | Page 3 of 7 |
SCHEDULE 13D
| CUSIP No. 81684M 104 | |
| 1. | NAMES OF REPORTING PERSONS
|
| WILLIAM H.C. CHANG | |
| 2. | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP |
| (a) ¨ (b) ¨ | |
| 3. | SEC USE ONLY
|
| 4. | SOURCE OF FUNDS
PF |
| 5. | CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2 (e)
¨ |
| 6. | CITIZENSHIP OR PLACE OF ORGANIZATION
United States |
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 7. | SOLE VOTING POWER
0 shares |
| 8. | SHARED VOTING POWER
1,400,419 shares | |
| 9. | SOLE DISPOSITIVE POWER
0 shares | |
| 10. | SHARED DISPOSITIVE POWER
1,400,419 shares |
| 11. | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,400,419 shares |
| 12. | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
¨ |
| 13. | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
23.5%* |
| 14. | TYPE OF REPORTING PERSON*
IN |
* Based upon an aggregate of 5,954,689 shares of the Issuer’s (as defined below) common stock outstanding as of May 1, 2018 as reported in the Issuer’s Annual Report on Form 10-Q filed on May 3, 2018.
| CUSIP No. 81684M 104 | Page 4 of 7 |
Item 1. Security and Issuer
The equity securities covered by this Schedule 13D (Amendment No. 6) are shares of common stock, $0.001 par value, of Semler Scientific, Inc., a Delaware corporation (the “Issuer”). The Issuer’s principal executive offices are located at 911 Bern Court, Suite 110, San Jose, CA 95112
Item 2. Identity and Background
This statement is filed jointly by William H.C. Chang, a U.S. citizen (“Mr. Chang”) and the Chang Family Trust, a California living revocable trust (the “Trust”) of which Mr. Chang is co-Trustee with his spouse. All of Mr. Chang’s securities are held in the Trust. Mr. Chang and the Trust are hereinafter collectively referred to as, the “Reporting Person”). The Reporting Person’s business address is 520 El Camino Real, 9th Floor, San Mateo, CA 94402, and present principal occupation is serving as Chief Executive Officer of Westlake Development Company and Chairman of Westlake International Group.
The Reporting Person has not during the last five years, (a) been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) or (b) been party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.
Item 3. Source and Amount of Funds or Other Consideration
The information contained in Item 4 is incorporated by reference into this Item 3.
Item 4. Purpose of Transaction.
On April 20, 2018, the Reporting Person acquired 71,925 shares of the Issuer’s common stock at $8.34 per share. On December 7, 2017 the Reporting Person acquired 228,572 shares of the Issuer's common stock at $1.75 per share upon the exercise of outstanding warrants.
The Reporting Person consummated the transactions described herein in order to acquire an interest in the Issuer for investment purposes. Depending upon future evaluations of the business prospects of the Issuer and upon other developments, including, but not limited to, general economic and business conditions and stock market conditions, the Reporting Person may purchase additional equity or other securities of the Issuer or dispose of some or all of his holdings in the open market, in public offerings, in privately negotiated transactions or in other transactions, or in any combination of the foregoing, subject to the Issuer’s insider trading policy and relevant applicable securities laws and regulations.
Except as set forth in this Item 4, the Reporting Person has no present plans or proposals that relate to, or that would result in, any of the actions specified in clauses (a) through (j) of Item 4 of Schedule 13D.
Item 5. Interest in Securities of the Issuer.
The Reporting Person is the beneficial owner of an aggregate of 1,400,419 shares of the Issuer’s common stock (approximately 23.5% based on 5,954,689 shares issued and outstanding on May 1, 2018). The Reporting Person shares voting and investment control over such shares with his spouse, as co-Trustee of the Chang Family Trust. Such beneficial ownership includes: (i) 1,265,803 shares of the Issuer’s common stock and 134,616 shares of the Issuer’s common stock issuable upon exercise of outstanding warrants, which have an exercise price of $2.60 per share and expire January 2022.
Other than the acquisition of an aggregate of 300,497 shares of the Issuer’s common stock described above in Item 4 of this Schedule 13D (Amendment No. 6), the Reporting Person has not effected any transaction in the Issuer’s common stock during the 60 days prior to the date of this Schedule 13D (Amendment No. 6).
| CUSIP No. 81684M 104 | Page 5 of 7 |
Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.
As a stockholder of the Issuer prior to its initial public offering (the “IPO”), the Reporting Person is party to the following agreements:
Investor Rights Agreement
In June 2012, all the holders of the Issuer’s then outstanding common stock and convertible preferred stock, including the Reporting Person, entered into an Investor Rights Agreement. This agreement currently provides for certain rights relating to the registration of the holders’ shares of common stock, which rights will terminate five years following the completion of the IPO, or for any particular holder with registration rights, at such time following the IPO when all securities held by that stockholder subject to registration rights may be sold pursuant to Rule 144 under the Securities Act of 1933, as amended during any ninety (90) day period.
Other than as described above, there are no other contracts, arrangements, understandings, or relationships (legal or otherwise) between Reporting Person and any other person with respect to the securities beneficially owned by the Reporting Person.
Item 7. Materials to be Filed as Exhibits
None.
| CUSIP No. 81684M 104 | Page 6 of 7 |
SIGNATURE
After reasonable inquiry and to the best of such Reporting Person’s knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct.
Dated: June 7, 2018
| /s/ William H.C. Chang | |
| William H.C. Chang | |
| WILLIAM H.C. & DIANA SHON CHANG TTEE CHANG FAMILY TRUST U/A DTD 10/23/2006 | |
| /s/ William H.C. Chang | |
| William H.C. Chang |
| CUSIP No. 81684M 104 | Page 7 of 7 |
EXHIBIT A
We, the undersigned, hereby express our agreement that the attached Schedule 13D, Amendment No. 6 is filed on behalf of each of us.
Dated: June 7, 2018
| /s/ William H.C. Chang | |
| William H.C. Chang | |
| WILLIAM H.C. & DIANA SHON CHANG TTEE CHANG FAMILY TRUST U/A DTD 10/23/2006 | |
| /s/ William H.C. Chang | |
| William H.C. Chang |